Navigation Links
Pharmasset to Present at Cowen & Company's Health Care Conference on Tuesday, March 18th
Date:3/10/2008

s. Clevudine, for the treatment of chronic HBV infection, is enrolling Phase 3 clinical trials for registration in North, Central and South America and Europe. Clevudine is already approved for HBV in South Korea and marketed by Bukwang Pharmaceuticals in South Korea under the brand name Levovir. R7128, an oral treatment for chronic HCV infection, is in a 4-week Phase 1 clinical trial in combination with Pegasys(R) plus Copegus(R) through a strategic collaboration with Roche. Racivir, which is being developed for the treatment of HIV in combination with other approved HIV drugs, has completed a Phase 2 clinical trial.

Pegasys(R) and Copegus(R) are registered trademarks of Roche.

Contact

Alan Roemer, Vice President

Investor Relations & Corporate Communications

alan.roemer@pharmasset.com

Office: +1 (609) 613-4125


'/>"/>
SOURCE Pharmasset, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Pharmasset to Present at Susquehannas Second Annual SIGnificant Investment Options in Healthcare Conference on Wednesday, March 5th
2. Pharmasset to Present at the BIO CEO & Investor Conference 2008 on Monday, February 11th
3. Pharmasset Reports Fiscal Year End 2007 Financial Results
4. Pharmasset Appoints Michael Rogers as Chief Development Officer
5. Pharmasset to Present at Three Investor Conferences in November 2007
6. Pharmasset Accesses up to $30 Million of Working Capital
7. Pharmasset to Present at the UBS Global Life Sciences Conference on Monday, September 24th
8. Pharmasset and Roche to Present R7128 Data at the 14th International Symposium on Hepatitis C Virus and Related Viruses
9. Halozyme Therapeutics Presents Favorable New Safety and Pharmacokinetic Data on rHuPH20 Enzyme Produced Via New Manufacturing Process at European Federation for Pharmaceutical Sciences
10. Alseres Pharmaceuticals Presents Inosine and Dopamine Transporter (DAT) Blocker Preclinical Data at the American Society for Experimental NeuroTherapeutics (ASENT) Conference
11. Media Advisory - Oncolytics Biotech Inc. to Present at BioSquare 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... 2014 The Microcompetition with Foreign DNA ... disease. One of these latent viruses is the Epstein ... rheumatoid arthritis (RA). Rheumatoid arthritis (RA) is a chronic ... by the theory, a study found that RA patients ... (1). , What is Microcompetition? , Dr. Hanan ...
(Date:1/15/2014)... Sunnyvale, CA (PRWEB) January 15, 2014 ... of high throughput research solutions, today announced that ... companies, has received delivery of Freeslate’s CM ... form screening. , Lupin, headquartered in Mumbai, ... quality, affordable generic and branded formulations and Active ...
(Date:1/14/2014)... (PRWEB) January 14, 2014 Date: Friday, ... p.m. , Location: Warrington Country Club, 1360 Almshouse Road, ... Foundation, the only national nonprofit organization solely dedicated to ... quality of life for those affected worldwide, will host ... Warrington Country Club in Warrington, Pa. , Each ...
(Date:1/14/2014)... , Jan. 14, 2014  3D Communications, a leading provider ... major scientific, regulatory, business, and media events in ... , today announced its former associate Virginia Cox , ... office. Virginia Cox re-joins ... Commissioner for the Office of External Affairs at the U.S. ...
Breaking Biology Technology:Study: Rheumatoid Arthritis (RA) Patients Have EBV; The CBCD Says this is Consistent with Microcompetition 2Study: Rheumatoid Arthritis (RA) Patients Have EBV; The CBCD Says this is Consistent with Microcompetition 3Lupin Selects Freeslate’s CM Protégé PharmD System to Accelerate Polymorph Screening for Drug Development 2Lupin Selects Freeslate’s CM Protégé PharmD System to Accelerate Polymorph Screening for Drug Development 3Hepatitis B Foundation to Host Annual Crystal Ball Gala 2Former FDA Associate Commissioner Returns To 3D Communications 2
... Gene Specific siRNA Controls , ... in siRNA , research or you ... convenience of the Silencer gene specific siRNA , ... contains 50 g of ready-to-use chemically synthesized and gel , ...
... , experiment depends ... expression vehicles (plasmids, PCR fragments) into cells. Many , ... reagents to deliver ... cells. The choice of reagent and the conditions under which it , ...
... Fluorescence activated cell sorting (FACS) is a , ... , individual cells using fluorescent probes that bind specifically ... is commonly used to collect , cells of a ... , Figure 1.Linear Amplification from 1-1000 Cells. ...
Cached Biology Technology:Control Your siRNA Research 2Control Your siRNA Research 3Choose the Right Transfection Agent for Your RNAi Experiment 2Choose the Right Transfection Agent for Your RNAi Experiment 3Choose the Right Transfection Agent for Your RNAi Experiment 4Choose the Right Transfection Agent for Your RNAi Experiment 5Choose the Right Transfection Agent for Your RNAi Experiment 6Choose the Right Transfection Agent for Your RNAi Experiment 7Cells-to-cDNA II Using FACS Sorted Cells 2
(Date:4/15/2014)... Reserve University dental researchers have found a less ... from the mouth to study how the mouth,s ... By isolating some specialized immune cells (white blood ... fight diseases in the mouthor reject foreign tissues, ... learn more about treating and preventing such health ...
(Date:4/15/2014)... form could help reduce side effects by targeting the ... have developed nanoparticles that deliver one or two chemotherapy ... particles that can carry any more than that in ... a new way to build such nanoparticles, making it ... In a paper published in the Journal of ...
(Date:4/15/2014)... By 2050, deforestation could cause temperatures in the ... increase would intensify warming caused by greenhouse gases ... at the University of Leuven, Belgium. , Explosive ... large-scale destruction of tropical rainforests in Central Africa. ... Leuven examined how these practices will affect longer-term ...
Breaking Biology News(10 mins):New method isolates immune cells for researchers to study how they ward off oral diseases 2Targeting cancer with a triple threat 2Targeting cancer with a triple threat 3Study: Deforestation could intensify climate change in Congo Basin by half 2
... finger as hard as you can against the surface. Now ... follow the ticking clock. Now faster. Now faster." These ... casts doubt on old ideas about mechanisms to control hand ... manual dexterity is so vulnerable to aging and disease, and ...
... developed salt-tolerant plants using a new type of genetic modification ... The research team based at the University of ... GM technique to contain salt in parts of the plant ... which means the results of this research could impact on ...
... 7, 2009) -- The Wildlife Conservation Society (WCS) announced today ... of the Amazon in Brazil. The monkey is related to ... their distinctively marked backs. The newly described distinct subspecies ... the state of Amazonas in northwestern Brazil. The discovery was ...
Cached Biology News:1-finger exercise reveals unexpected limits to dexterity 21-finger exercise reveals unexpected limits to dexterity 3Scientists closer to developing salt-tolerant crops 2New monkey discovered in Brazil 2
Request Info...
... Freezer Inventory Storage Racks for Standard ... to fit all makes and models ... Made of high quality stainless steel ... fiberboard, stainless steel or plastic boxes. ...
Immunogen: Recombinant rabbit tryptophan hydroxylase, isolated as inclusion bodies from E. coli and purified by preparative SDS-PAGE. Storage: -20 C, Avoid Freeze/Thaw Cycles...
Chlorine-36, 3.7 MBq, 100 uCi. 0.1-0.3 HCl.< 111 MBq/g Cl, < 3 mCi/g Cl.Dispensed to order. Please inquire for alternative pack sizes. Category: Radiochemicals &Radiation Safety, Radiochemicals....
Biology Products: